Vipin Dixena

@vipin.dixena.4108

Chhattisgarh

5+ Years of experience

SEBI Registration INH000014076

Trade Ideas

Opinions

254

Followers

165

Expertise

Quantitative

Growth

Technical

Index Strategies

Market Commentary

Futures & Options

Technical Analysis

Trade Facts

Total Trades

Missed Trades

Profit Trades

Accuracy

Ask me Anything

Got a question? Ask me and I will answer it. Stay curious, stay hungry!

Posts

shared an insight ⚡️ 15 hours ago

Softbank Selling This Shares in The Indian Equity Market

Japanese investment giant SoftBank continues to reduce its exposure to listed Indian technology companies. Its affiliate, SVF II Meerkat (DE) LLC, sold shares of Meesho on 13 November. Key Transaction Highlights - Shares sold: 7.64 crore - Stake diluted: 1.65% - Transaction value: ₹1,885.17 crore - Average selling price: ₹246.75 per share - SoftBank's holding reduced: 6.84% to 5.19% Societe Generale emerged as the largest buyer, acquiring shares worth approximately ₹364.65 crore. Several other institutional investors, including Fidelity, Morgan Stanley, Goldman Sachs and domestic mutual funds, also participated. Which Other Indian Stocks Has SoftBank Sold in 2026? SoftBank has been monetising several investments this year: - Lenskart: Sold 3.25% stake for ₹2,873 crore in June. - Lenskart: Sold nearly 2.6% stake for ₹2,888 crore in August. - Meesho: Sold 1.7% stake for ₹1,650 crore in September. - Lenskart: Sold 1.56% stake for ₹1,896 crore in November. - Ola Electric: Reduced its holding by 2.15% in January. My View I would interpret these transactions primarily as portfolio monetisation rather than an automatic signal of deteriorating business fundamentals. Large early-stage investors such as SoftBank typically exit investments in phases to realise returns, manage portfolio exposure and unlock capital. However, repeated stake sales can create short-term supply pressure and influence investor sentiment. An important aspect of this transaction is that institutional investors absorbed the shares, indicating continued participation from large domestic and global investors. For Meesho ( MEESHO ) shareholders, I would focus more on revenue growth, profitability, cash burn, customer retention and the sustainability of its business model than on one investor's selling activity.

232

shared an insight ⚡️ 21 hours ago

Insurance Industry October 2026 Updates : Key Numbers

India's non-life insurance industry reported a 10.5% year-on-year increase in gross direct premium income to ₹32,761 crore in October 2026, according to provisional data released by the General Insurance Council. The standout performer was the standalone health insurance segment, which continued to grow significantly faster than the broader industry. Key October 2026 Highlights - Total non-life insurance premiums: ₹32,761 crore, up 10.5% YoY - General insurers: ₹28,062 crore, up 10.15% - Standalone health insurers: ₹4,549 crore, up 21.29% - April–October FY27 industry premium growth: 9.13% to ₹2.12 lakh crore - Standalone health insurers' Apr–Oct growth: 29.18% Among general insurers: - HDFC ERGO: Premium income up 34.87% to ₹1,662 crore - SBI General : Up 31.98% to ₹1,550 crore - IFFCO-Tokio: Up 18% to ₹974 crore - Tata AIG: Up 15% to ₹2,265 crore - Bajaj General: Up 12.14% to ₹2,142 crore - ICICI Lombard : Up 9.69% to ₹2,826 crore - Go Digit: Declined 3.23% to ₹967 crore ( GODIGIT ) Among standalone health insurers: - Care Health: Up 34.56% to ₹1,129 crore - Niva Bupa : Up 20.05% to ₹826 crore - Star Health : Up 17.65% to ₹1,721 crore My View The October data reinforces the structural growth opportunity in India's insurance sector, particularly health insurance. Rising healthcare costs, greater awareness and increasing insurance penetration can support long-term demand. However, premium growth alone does not determine profitability. Investors should also track underwriting discipline, claims ratios, combined ratios, distribution costs and renewal retention. I would particularly watch standalone health insurers, which are currently growing faster than the broader general insurance industry. At the same time, faster premium growth does not automatically translate into better shareholder returns. For listed insurers, the quality of growth and the ability to generate sustainable underwriting profits will matter more than headline premium expansion.

312

shared an insight ⚡️ 13th Nov

MSTC Q2 FY27 Updates: Profit Jumps 57.7%

MSTC ( MSTCLTD ) shares surged 20% to hit the upper circuit today after the state-owned company reported its strongest second-quarter performance since listing in 2019. Key Q2 FY27 Highlights - Consolidated revenue from operations: ₹110.02 crore, up 29.4% YoY - Consolidated net profit: ₹74.92 crore, up 57.7% YoY - Profit before tax: ₹99.85 crore, up 54.8% YoY - Total income: ₹139.21 crore, up 36.1% YoY - Total expenses: ₹39.67 crore, up 9.8% YoY - H1 FY27 e-commerce transaction value: ₹54,580 crore What Is Driving the Growth? MSTC's e-commerce business remains its key growth engine. During the quarter, the company facilitated several significant transactions, including Hyderabad land parcel auctions worth ₹2,863 crore and Karnataka liquor licence auctions that generated approximately ₹125 crore for the state government. Another important development is the RBI's in-principle authorisation, received on November 11, to establish and operate a Trade Receivables Discounting System (TReDS) platform. This could open an additional business opportunity in the MSME financing ecosystem, subject to fulfilment of regulatory conditions. The company is also examining the feasibility of establishing coal and other mineral exchanges. My View MSTC's Q2 performance is encouraging, particularly because profitability has grown faster than revenue. The relatively slower increase in expenses has supported earnings expansion. I also find the TReDS opportunity strategically interesting. If successfully operationalised, it could diversify the company's revenue streams beyond its existing e-commerce and auction activities. However, investors should remember that RBI's in-principle approval is not the same as a fully operational platform. After a sharp 20% rally, I would avoid chasing the stock purely on momentum. The business momentum is improving, but investors should focus on earnings sustainability rather than just the upper-circuit movement.

566

What are the top stock recommendations by Vipin Dixena?

Vipin Dixena regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include MEESHO, GODIGIT and MSTCLTD. Explore Vipin Dixena's complete list of posts and trade views on their StockGro profile.

How can I follow Vipin Dixena's latest investment insights?

You can follow Vipin Dixena's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.

What is Vipin Dixena's investment strategy?

Vipin Dixena follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.

How long has Vipin Dixena been a SEBI-registered Research Analyst (RA)?

Vipin Dixena has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.

Where can I see Vipin Dixena's past performance and stock picks?

You can check Vipin Dixena's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.

How can I contact Vipin Dixena for stock market advice?

For stock market guidance from Vipin Dixena, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.

What is Vipin Dixena's track record in predicting market movements?

Vipin Dixena has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.

What is the SEBI Registration number for Vipin Dixena?

Vipin Dixena is a SEBI-registered Research Analyst with the SEBI Registration INH000014076. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.

Be Financially Free with StockGro